Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and indentification of risk factors.

Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and indentification of risk factors.

Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and indentification of risk factors.

ESCRS Endophthalmitis Group

J. Cataract. Surg. 2007, 33:978-988.

2007

Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.

Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.

Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.

Macugen AMD Study Group

Ophthalmology. 2007; 114:1702-1712.

2007

Intercurrent Factors Associated with the Development of Open-Angle Glaucoma in the European Glaucoma Prevention Study.

Intercurrent Factors Associated with the Development of Open-Angle Glaucoma in the European Glaucoma Prevention Study.

Intercurrent Factors Associated with the Development of Open-Angle Glaucoma in the European Glaucoma Prevention Study.

Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I; The European Glaucoma Prevention Study (EGPS) Group

Am J Ophthalmol. 2007 Aug; 144(2):266-275.

2007

Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.

Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.

Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.

Nardi, M., Lobo, C., Bereczki, A., Cano, J., Zagato, E., Potts, S., Sullins, G., Notivol, R., for the International C-04-65 Study Group

Clinical Ophthalmology 2007:1(4) 527-533.

2007